Get the Stockscreener App
71.23
0.37%
0.2416
Edwards Lifesciences Corp stock is traded at $71.23, with a volume of 1.20M.
It is up +0.37% in the last 24 hours and down -3.25% over the past month.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
See More
Previous Close:
$70.99
Open:
$71.19
24h Volume:
1.20M
Relative Volume:
0.27
Market Cap:
$41.87B
Revenue:
$6.60B
Net Income/Loss:
$4.16B
P/E Ratio:
10.28
EPS:
6.93
Net Cash Flow:
$490.10M
1W Performance:
-1.66%
1M Performance:
-3.25%
6M Performance:
+16.67%
1Y Performance:
-17.73%
1-Day Range:
$70.86
$71.68
1-Week Range:
$70.65
$72.36
52-Week Range:
$58.93
$96.12
Edwards Lifesciences Corp Stock (EW) Company Profile
Name
Edwards Lifesciences Corp
Sector
Industry
Phone
(949) 250-2500
Address
ONE EDWARDS WAY, IRVINE, CA
Compare EW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
71.24 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
|
ABT
Abbott Laboratories
|
129.26 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.58 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.80 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.00 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Upgrade | Stifel | Hold → Buy |
| Jan-16-25 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Dec-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-11-24 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-18-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jul-29-24 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jul-25-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-25-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-25-24 | Downgrade | TD Cowen | Buy → Hold |
| Jul-25-24 | Downgrade | Truist | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| May-14-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-07-24 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Nov-28-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-26-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-08-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-06-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-31-23 | Downgrade | Bernstein | Outperform → Underperform |
| Jan-30-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-06-22 | Downgrade | Stifel | Buy → Hold |
| Oct-28-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-26-22 | Initiated | Mizuho | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-29-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-27-22 | Reiterated | Citigroup | Buy |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | UBS | Neutral |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-30-21 | Reiterated | Canaccord Genuity | Buy |
| Jul-30-21 | Reiterated | Deutsche Bank | Hold |
| Jul-30-21 | Reiterated | Jefferies | Buy |
| Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-30-21 | Reiterated | Oppenheimer | Outperform |
| Jul-30-21 | Reiterated | Stifel | Buy |
| Jul-30-21 | Reiterated | UBS | Neutral |
| Jul-30-21 | Reiterated | Wells Fargo | Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Apr-05-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-11-20 | Reiterated | Canaccord Genuity | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Underperform |
| Apr-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-17-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Outperform |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-24-19 | Reiterated | Canaccord Genuity | Buy |
| Sep-23-19 | Initiated | Piper Jaffray | Overweight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Mar-18-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-16-18 | Initiated | Barclays | Underweight |
| Oct-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-02-18 | Downgrade | Guggenheim | Buy → Neutral |
View All
Edwards Lifesciences Corp Stock (EW) Latest News
Ninety One SA PTY Ltd Has $3.93 Million Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Stock Holdings Lessened by Telos Capital Management Inc. - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Caprock Group LLC Invests $623,000 in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
One Wealth Advisors LLC Sells 5,305 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
4,179 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by Heck Capital Advisors LLC - MarketBeat
Chicago Capital LLC Trims Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Lockheed Martin Investment Management Co. Takes Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Weaver Capital Management LLC Has $791,000 Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
abrdn plc Cuts Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Ninety One UK Ltd Has $531.88 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Boston Trust Walden Corp Increases Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Robeco Institutional Asset Management B.V. Trims Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Ninety One North America Inc. Sells 15,015 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025 - Marketscreener.com
GDS Wealth Management Acquires 60,339 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Forsta AP Fonden Reduces Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says - Reuters
7,509,650 Shares in Edwards Lifesciences Co. (NYSE:EW) Purchased by Jennison Associates LLC - MarketBeat
Swedbank AB Sells 189,026 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Wolfe Research Downgrades Edwards Lifesciences (EW) - MSN
BDF Gestion Decreases Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences (NYSE:EW) Rating Increased to Buy at Stifel Nicolaus - MarketBeat
Union Bancaire Privee UBP SA Takes $1.12 Million Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences (EW) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
Edwards Lifesciences Corporation (EW): A Bull Case Theory - Yahoo Canada Finance
Sivik Global Healthcare LLC Acquires Shares of 50,000 Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
OLD National Bancorp IN Acquires 7,066 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Vanguard Group Inc's Strategic Acquisition of Edwards Lifescienc - GuruFocus.com
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MSN
11 Analysts Have This To Say About Edwards LifesciencesEdwards Lifesciences (NYSE:EW) - Benzinga
This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Stifel Upgrades Edwards Lifesciences to Buy From Hold, Adjusts Price Target to $90 From $75 - Marketscreener.com
Stifel raises Edwards Lifesciences stock to buy, target to $90 - MSN
KBC Group NV Sells 248,320 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Decreases Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO - Orange County Business Journal
Agree To Purchase Edwards Lifesciences At $55, Earn 7.8% Using Options - Nasdaq
Baldwin Wealth Partners LLC MA Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
United Asset Strategies Inc. Has $12.45 Million Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Stonehage Fleming Financial Services Holdings Ltd - MarketBeat
CX Institutional Buys New Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Harrell Investment Partners LLC Sells 12,378 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Park Avenue Securities LLC - MarketBeat
EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences CorporationEW - Business Wire
Smart Money Is Betting Big In Edwards Lifesciences Options - Benzinga
Manitou Investment Management Ltd. Increases Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corp Stock (EW) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):